Scott Allocco '82, president of BioMarker Strategies, LLC, is an invited presenter at a biotech conference on October 22 sponsored by The Mid-Atlantic Venture Association and VA, DC and MD Biotechnology Associations. He will be discussing his company's effort to develop the SnapPath tumor cell processing and testing system, which is being coordinated by its Director of Research & Development, Dr. Adam Schayowitz '03. The company is based at the Johns Hopkins Science + Technology Park in Baltimore. Allocco has more than 14 years of healthcare and pharmaceutical industry experience, including
drug coverage and reimbursement issues for Medicare and Medicaid healthcare programs. He graduated cum laude with a B.A. degree in Public Policy from Hamilton College. For more about BioMarker Strategies visit the Web site.
drug coverage and reimbursement issues for Medicare and Medicaid healthcare programs. He graduated cum laude with a B.A. degree in Public Policy from Hamilton College. For more about BioMarker Strategies visit the Web site.
